Noshena Khan
Overview
Explore the profile of Noshena Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu H, Rogowskyj J, Yu W, Venkatesh A, Khan N, Nakagawa S, et al.
Bioorg Med Chem Lett
. 2016 Oct;
26(23):5819-5824.
PMID: 27793566
Based on our previous identification of a disubstituted aminothiazole termed HBF-0079 with promising selective toxicity for HCC-derived cell lines versus non-HCC liver lines, a series of tri-substituted aminothiazole derivatives were...
2.
Du Y, Ye H, Guo F, Wang L, Gill T, Khan N, et al.
Bioorg Med Chem Lett
. 2013 Jun;
23(14):4258-62.
PMID: 23747225
Novel N-alkyldeoxynojirimycins (NADNJs) based on our previous lead 3 were designed, synthesized and tested in metabolic assays and in virus cultures. NADNJs containing terminal tertiary benzamide, sulfonamide, urea, and oxazolidinone...
3.
Wang P, Chun B, Rachakonda S, Du J, Khan N, Shi J, et al.
J Org Chem
. 2009 Aug;
74(17):6819-24.
PMID: 19642660
R7128 is the prodrug of 2'-deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130), a potent and selective inhibitor of HCV NS5B polymerase. Currently, R7128 is in clinical trials for the treatment of HCV infection. To support...